A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
Condition(s):Ovarian Cancer; Platinum-resistant Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube CancerLast Updated:June 18, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Ovarian Cancer; Platinum-resistant Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube CancerLast Updated:June 18, 2023Recruiting
Condition(s):High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerLast Updated:March 12, 2024Recruiting
Condition(s):Uterine Serous CarcinomaLast Updated:March 20, 2024Recruiting
Condition(s):Advanced Fallopian Tube Carcinoma; Advanced Ovarian Carcinoma; Advanced Primary Peritoneal Carcinoma; Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Carcinoma; Stage III Fallopian Tube Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Primary Peritoneal Cancer AJCC v8; Stage IV Fallopian Tube Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Primary Peritoneal Cancer AJCC v8Last Updated:May 6, 2023Withdrawn
Condition(s):Solid TumorLast Updated:February 1, 2023Recruiting
Condition(s):OsteosarcomaLast Updated:November 14, 2023Active, not recruiting
Condition(s):Metastatic Colorectal CancerLast Updated:March 8, 2024Recruiting
Condition(s):Advanced Pancreatic Adenocarcinoma; Pancreatic Cancer; Pancreatic Ductal AdenocarcinomaLast Updated:December 20, 2023Recruiting
Condition(s):Solid Tumor; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal CancerLast Updated:September 21, 2023Recruiting
Condition(s):Solid TumorsLast Updated:September 5, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.